# EDWARDS LIFESCIENCES CORPORATION (EW) FY2024 Q3 Balance Sheet

- Company: EDWARDS LIFESCIENCES CORPORATION (EW)
- Period: As of 2024-09-30
- Filing: Q3 FY2024 10-Q, filed 2024-11-06, accession number 0001099800-24-000086
- Page: https://plicit.ai/financials/ew/fy2024-q3-balance-sheet
- Chart image: https://plicit.ai/charts/ew-fy2024-q3-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2024-09-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 12,971,200,000 US dollars
- **Current assets**: 6,727,700,000 US dollars
- **Non-current assets**: 6,243,500,000 US dollars
- **Liabilities**: 3,359,800,000 US dollars
- **Current liabilities**: 1,944,100,000 US dollars
- **Non-current liabilities**: 1,415,700,000 US dollars
- **Equity**: 9,611,400,000 US dollars
- **Noncontrolling interest**: 65,800,000 US dollars. Included in consolidated equity; this amount is not added again.
- **Cash and cash equivalents**: 3,676,400,000 US dollars
- **Inventories (Note 2)**: 1,104,200,000 US dollars
- **Short-term investments (Note 6)**: 769,700,000 US dollars
- **Accounts receivable, net of allowances of $12.6 and $8.2, respectively**: 716,000,000 US dollars
- **Other current assets**: 231,000,000 US dollars
- **Prepaid expenses**: 114,900,000 US dollars
- **Other receivables**: 95,500,000 US dollars
- **Current assets of discontinued operations (Note 5)**: 20,000,000 US dollars
- **Property, plant, and equipment, net**: 1,675,700,000 US dollars
- **Goodwill**: 1,605,300,000 US dollars
- **Other intangible assets, net**: 956,100,000 US dollars
- **Deferred income taxes**: 888,400,000 US dollars
- **Other assets (Note 2)**: 683,500,000 US dollars
- **Long-term investments (Note 6)**: 319,600,000 US dollars
- **Operating lease right-of-use assets**: 104,400,000 US dollars
- **Non-current assets of discontinued operations (Note 5)**: 10,500,000 US dollars
- **Accrued and other liabilities (Note 2)**: 1,745,300,000 US dollars
- **Accounts payable**: 172,800,000 US dollars
- **Operating lease liabilities**: 24,200,000 US dollars
- **Current liabilities of discontinued operations (Note 5)**: 1,800,000 US dollars
- **Long-term debt**: 597,500,000 US dollars
- **Uncertain tax positions**: 345,600,000 US dollars
- **Other liabilities**: 322,600,000 US dollars
- **Operating lease liabilities**: 85,000,000 US dollars
- **Litigation settlement accrual**: 63,900,000 US dollars
- **Taxes payable**: 1,100,000 US dollars
- **Non-current liabilities of discontinued operations (Note 5)**: 0 US dollars
- **Retained earnings**: 12,781,400,000 US dollars
- **Additional paid-in capital**: 2,452,100,000 US dollars
- **Common stock, $1.00 par value, 1,050.0 shares authorized, 654.3 and 650.5 shares issued, and 589.8 and 601.1 shares outstanding, respectively**: 654,300,000 US dollars
- **Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding**: 0 US dollars
- **Noncontrolling interest**: 65,800,000 US dollars
- **Treasury stock, at cost, 64.5 and 49.4 shares, respectively**: negative 6,089,700,000 US dollars
- **Accumulated other comprehensive loss (Note 14)**: negative 252,500,000 US dollars
- **Gross equity (calculated)**: 15,953,600,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.